History of pancreatic cancer status post 12 cycles of chemotherapy. Evaluate for response. ABDOMEN:LIVER, BILIARY TRACT: The liver is normal in morphology size and signal intensity.Cholelithiasis without acute cholecystitis. Normally distended gallbladder. Punctate segment 3 cystic focus is too small to characterize but is unchanged and likely a cyst (series 3 image 19)No suspicious liver lesion, biliary ductal dilatation or vascular abnormality.SPLEEN: No significant abnormality noted.PANCREAS: Poorly defined pancreatic uncinate process soft tissue measures approximately 1.8 x 1.7 cm (series 12/35). The soft tissue encases the adjacent SMA and moderately narrows the SMV portal vein confluence. The portal vein is patent. There is pancreatic atrophy distally. Adjacent to the pancreatic tail there is an unchanged soft tissue nodule measuring approximately 1 cm (series 12/62).ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Bilateral renal cysts and too small to characterize hyperintensities.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
Mild interval decrease in the pancreatic head lesion and nodule near the pancreatic tail. The difference in size likely represents a combination of treatment response and modality technical differences. No new sites of disease.